The Oaks At Woodfield | |
5370 E Baldwin Road, Grand Blanc, Michigan 48439 | |
(810) 606-9950 | |
Name | The Oaks At Woodfield |
---|---|
Location | 5370 E Baldwin Road, Grand Blanc, Michigan |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 51 |
Occupancy Rate | 92.16% |
Medicare ID (CCN) | 235660 |
Legal Business Name | Trilogy Healthcare Of Genesee, Llc |
Ownership Type | For Profit - Corporation |
NPI Number | 1811259732 |
Organization Name | TRILOGY HEALTHCARE OF GENESEE, LLC |
Doing Business As | THE OAKS AT WOODFIELD |
Address | 5370 E. Baldwin Road, Grand Blanc, MI 48439 |
Phone Number | 810-606-9950 |
News Archive
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Research carried out by the University has discovered the first data on an organelle that is really important in human cells in an ancient organism distantly related to humans.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Medical Device Network has named the LifeVest® Wearable Defibrillator as one of the five most innovative and life-changing medical devices of 2009.
› Verified 3 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Research carried out by the University has discovered the first data on an organelle that is really important in human cells in an ancient organism distantly related to humans.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Medical Device Network has named the LifeVest® Wearable Defibrillator as one of the five most innovative and life-changing medical devices of 2009.
› Verified 3 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $650 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 10 | 14.46 |
Percentage of long-stay residents who lose too much weight | 4.6 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 41.38 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.97 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 3.67 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 0.92 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 8.85 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 99.12 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 13.64 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 96.47 | 83.88 |
Percentage of short-stay residents who newly received an antipsychotic medication | 2.12 | 1.79 |
Percentage of long-stay residents whose ability to move independently worsened | 27.92 | 17.09 |
Percentage of long-stay residents who received an antianxiety or hypnotic medication | 15.38 | 19.7 |
Percentage of high risk long-stay residents with pressure ulcers | 7.22 | 7.32 |
Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 86.13 | 95.98 |
Percentage of short-stay residents who made improvements in function | 53.65 | 67.99 |
Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 88.86 | 82.93 |
News Archive
BrainCool AB, a Swedish medical device innovator, and a world leader in medical cooling technology for therapeutic hypothermia (brain cooling) and oncology, is pleased to announce that it has completed patient recruitment in the Scandinavian multi-center pivotal trial of 180 patients to investigate the patented Cooral® System for prevention of Oral Mucositis, one of the most debilitating side-effects of both standard and high-dose chemotherapeutic oncology treatments.
Research carried out by the University has discovered the first data on an organelle that is really important in human cells in an ancient organism distantly related to humans.
Brainlab announced the availability of ExacTrac® Infrared Monitoring, an add-on device to existing treatment machines for monitoring patient positioning during radiation therapy treatments, at the American Association of Physicists in Medicine (AAPM) Annual Meeting last week.
ZOLL Medical Corporation, a manufacturer of medical devices and related software solutions, announced today that the Medical Device Network has named the LifeVest® Wearable Defibrillator as one of the five most innovative and life-changing medical devices of 2009.
› Verified 3 days ago
Wellbridge Of Grand Blanc Location: 3139 East Baldwin Road, Grand Blanc, Michigan 48439 Phone: (810) 445-5300 | |
The Oaks At Woodfield Location: 5370 E Baldwin Road, Grand Blanc, Michigan 48439 Phone: (810) 606-9950 | |
Regency At Grand Blanc Location: 1330 Grand Pointe Court, Grand Blanc, Michigan 48439 Phone: (810) 695-8920 | |
Genesys Short-term Rehabilitation Center Location: One Genesys Parkway, Grand Blanc, Michigan 48439 Phone: (810) 606-6190 |